Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: CTEPH
Secondary Audience: PH

Session Summary: Interventional options for the treatment of CTEPH are expanding with BPA recently emerging as an option, in addition to PTE surgery. Yet, how can we compare the two therapies when there are differences in patient populations, procedures performed, and variability in reporting of risks and outcomes? This symposium will address these issues and facilitate discussion on how we can move toward more uniform reporting of outcomes.

Chairs: Isabelle Opitz, MD and Gustavo A. Heresi, MD
 

7:00 AM	Challenges in Risk Stratification of CTEPH Patients Raymond L. Benza, MD, Allegheny General Hospital, Pittsburgh, PA, USA
7:15 AM	Therapeutic Outcomes: Beyond Mortality, What Are the Other Important Endpoints? Marion Delcroix, MD, University Hospital Leuven, Leuven, Belgium
7:30 AM	Balloon Pulmonary Angioplasty: Defining Essential Differences in Procedure Technique and Uniform Definitions of Complications Aiko Ogawa, MD, Okayama Medical Center, Okayama, Japan
7:45 AM	Can We Compare Apples to Oranges? How Can We Design a Meaningful Trial to Compare PTE and BPA? William Auger, MD, UCSD Medical Center, La Jolla, CA, USA

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: HF/HTX
Secondary Audience: PHARM

Session Summary: Immunosuppression management balances the risks of under-immunosuppression and allograft rejection with the risks of over-immunosuppression and infection. Recent studies have demonstrated the efficacy of tacrolimus monotherapy, the utility of gene-expression profiling and the T-cell immune monitoring assay for minimization of immunosuppression. This symposium will serve to review approaches to minimization of immunosuppression as well as the pros and cons.

Chairs: Christina Aquilante, PharmD and Douglas Greig, MD
 

7:00 AM	The ABCs of Immunosuppression: Patient Profiles and Personalized Therapy Eugene DePasquale, MD, UCLA Medical Center, Los Angeles, CA, USA
7:15 AM	The Nuts and Bolts of Tailoring Immunosuppression: Impact on Long-Term Issues in Heart Transplantation Marisa G. Crespo-Leiro, MD, Hospital University A Coruña, La Coruña, Spain
7:30 AM	Minimizing Immunosuppression: Do All Roads Lead Home? Satish Arora, MD, Oslo University Hospital, Oslo, Norway
7:45 AM	15-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: LF/LTX
Secondary Audience: ID, NHSAH, PEDS

Session Summary: Guidelines for lung transplant candidacy were last updated in 2014 and include significant numbers of absolute and strong relative contraindications. In the last 5 years there has been a dramatic increase in the willingness of transplant programs to push the boundaries of transplant candidacy and a concomitant increase in the published literature regarding extended criteria recipients. This symposium focuses on several potential avenues for increased lung transplant candidate access.

Chairs: Edward Cantu, III, MD and Mark Benzimra, MD
 

7:00 AM	Is HIV a Contra-Indication for Lung Transplant? Paolo Grossi, MD, PhD, University of Insubria, Varese, Italy
7:15 AM	Scleroderma: The Ability to Swallow is Optional Maria M. Crespo, MD, University of Pennsylvania, Philadelphia, PA, USA
7:30 AM	So Many Antibodies... Adriana Zeevi, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
7:45 AM	15-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: NHSAH
Secondary Audience: HF/HTX, LF/LTX, MCS

Session Summary: A multi-disciplinary approach to the assessment and treatment of a complex frail patient will be highlighted. A case study describing a patient with end stage disease will be presented who is experiencing nutritional, cognitive, and mental health concerns. Individual talks addressing these issues will be from a physician, psychologist, and dietitian. The symposium will conclude by involving the audience in an open discussion on issues raised in one's clinical experience with frail patients.

Chairs: Louise M. Fuller, PT and Rose DeRosa, PA-C
 

7:00 AM	Dying, Not Necessarily Doomed Oscar Gonzalez Fernandez, MD, Hospital Universitario La Paz, Madrid, Spain
7:15 AM	Cognitive Deficits, Not Necessarily Crazy Patrick J. Smith, PhD, MPH, Duke University Medical Center, Durham, NC, USA
7:30 AM	Withered, Not Necessarily Wasted Kirsten Diegel, RD, LDN, Temple University Hospital, Philadelphia, PA, USA
7:45 AM	15-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: PEDS
Secondary Audience: LF/LTX, PATH

Session Summary: With improvements in the care of children with cystic fibrosis and pulmonary hypertension, the demographics of pediatric lung and heart lung transplantation are changing. This symposium will focus on the new demographics of pediatric lung and heart lung transplant recipients, the new challenges, and the impacts of these changes on pediatric transplant programs.

Chairs: Melinda P. Solomon, MD, FRCPC and Marc G. Schecter, MD
 

7:00 AM	The Changing Pediatric Lung Transplant Recipient Samuel B. Goldfarb, MD, Children's Hospital of Philadelphia, Philadelphia, PA, USA
7:15 AM	Q&A
7:20 AM	Childhood Interstitial Lung Disease (ChiLD) and Transplant Nicolaus Schwerk, MD, Hannover Medical School, Hannover, Germany
7:35 AM	Q&A
7:40 AM	When One is Not Enough - Indications for Heart Lung Transplant Maria C. Gazzaneo, MD, Texas Children's Hospital, Houston, TX, USA
7:55 AM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: PHARM
Secondary Audience: MCS

Session Summary: ECMO presents unique drug dosing and medication management challenges. This symposium will discuss the approach to optimal pharmacotherapy management for ECMO patients with a focus on anti-infectives and anticoagulation. Anecdotes and clinical pearls for ECMO in special populations will also be discussed.

Chairs: Patricia Uber, PharmD and Charles Hoopes, MD
 

7:00 AM	Keeping Things Moving: Anticoagulation on ECMO Christopher Michaud, PharmD, BCPS, Spectrum Health, Grand Rapids, MI, USA
7:15 AM	Q&A
7:20 AM	What's My Vd Again? Drug Dosing on ECMO with a Focus on Anti-Infectives Haifa Lyster, MSc, Royal Brompton, Middlesex, UK
7:35 AM	Q&A
7:40 AM	ECMO and What Else? Approach to Management of ECMO in Special Populations Konrad Hoetzenecker, MD, PhD, Medical University of Vienna, Vienna, Austria
7:55 AM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: ALL

Chairs: Stuart Sweet, MD, PhD and Stephan M. Ensminger, MD, DPhil
 

8:00 AM	Awards Presentations Kathleen L. Grady, PhD, APN, FAAN, Northwestern Memorial Hospital, Chicago, IL, USA
8:30 AM	What's Hot, What's New: Basic Science Overview Stijn E. Verleden, PhD, KU Leuven, Leuven, Belgium
8:50 AM	What’s Hot, What’s New: Clinical Science Overview Maria Rosa Costanzo, MD, Midwest Heart Specialists-Advocate Medical, Naperville, IL, USA
9:10 AM	PRESIDENT'S DEBATE: Resource Limits: It’s Time to Abandon Retransplantation (PRO) Josef Stehlik, MD, MPH, University of Utah School of Medicine, Salt Lake City, UT, USA
9:30 AM	PRESIDENT'S DEBATE: Resource Limits: It’s Time to Abandon Retransplantation (CON) Andrew J. Fisher, FRCP, PhD, Newcastle University, Newcastle Upon Tyne, UK
9:10 AM	Debate Rebuttal (PRO) - Josef Stehlik, MD, MPH
9:30 AM	Debate Rebuttal (CON) - Andrew J. Fisher, FRCP, PhD

Primary Audience: BSTR
Secondary Audience: HF/HTX, LF/LTX, PHARM
Session Summary: The goal of this symposium is to provide the audience with a deeper understanding of antibody-mediated mechanisms and potential downstream consequences of antibodies in transplantation. Presentations will discuss the basic science of immunology, the role of donor specific antibodies and emerging management strategies.

Chairs: Jon A. Kobashigawa, MD and Edward Horn, PharmD, BCPS
 

10:15 AM	The Pre-Transplant Alphabet Soup – MFI, C1Q, HLA Christine Falk, MD, Hannover Medical School, Hannover, Germany
10:30 AM	Seeing Ghosts? The Role of Non-DSA and Non-HLA in the Transplant Recipient Antoine Roux, MD, Hôpital Foch, Paris, France
10:45 AM	The Needles in the Haystack: Diagnostic Challenges in Antibody-Mediated Rejection Agnieszka Ciarka, MD, PhD, Catholic University of Leuven, Leuven, Belgium
11:00 AM	The Transplant Toolbox: Dealing with DSA Now and in the Future Miae Kim, PharmD, Brigham & Women's Hospital, Boston, MA, USA
11:15 AM	DEBATE: Photopheresis is Useful for Rejection Management (PRO) Peter Jaksch, MD, Medical University of Vienna, Vienna, Austria
11:30 AM	DEBATE: Photopheresis is Useful for Rejection Management (CON) Michael Shullo, PharmD, University of West Virginia, Morgantown, WV, USA
11:45 AM	15-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: CTEPH
Secondary Audience: PH

Chairs: Andrea M. G. D'Armini and Michael M. Madani, MD
 

10:15 AM	(294) Preoperative C-Reactive Protein Predicts Early Postoperative Outcomes after Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension J. Arthur1, M. Amsallem1, J. Guihaire2, F. Haddad3, L. Lamrani1, S. Feuillet4, F. Stephan5, X. Jais6, M. Humbert7, G. Simonneau7, O. Mercier4, E. Fadel4. 1Research and Innovation Unit, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France, 2Adult Cardiac Surgery, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France, 3Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, CA, 4Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France, 5Adult Intensive Care Unit, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France, 6Respiratory Medicine, Kremlin Bicetre Hospital, Paris Sud University, Kremlin Bicêtre, France, 7Respiratory Medicine, Kremlin Bicetre Hospital, Paris Sud University, Kremlin Bicetre, France
10:30 AM	(295) Right Ventricular Reverse Remodeling after Pulmonary Endarterectomy in Patients with Chronic Thrombo Embolic Pulmonary Hypertension S. Guimaron1, J. Guihaire1, M. Amsallem1, A. Potier2, A. Amatogauberville3, L. Mabille4, M. Isorni3, L. Lamrani1, E. Fadel5, O. Mercier5. 1Research and Innovation Unit Research Lab, Marie Lannelongue Hospital, Le Plessis Robinson, France, 2Marie Lannelongue Hospital, Le Plessis Robinson, France, 3Department of Radiology, Marie Lannelongue Hospital, Le Plessis Robinson, France, 4Department of Nuclear Medicine and Radiology, Marie Lannelongue Hospital, Le Plessis Robinson, France, 5Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Le Plessis Robinson, France
10:45 AM	(296) Outcome after Pulmonary Endarterectomy for Segmental Chronic Thromboembolic Pulmonary Hypertension M. de Perrot1, K. McRae1, L. Donahoe1, M. McInnis1, J. Thenganatt1, A. Bykova1, K. Tan1, J. Moric1, S. Mak2, J. Granton1. 1Toronto General Hospital, Toronto, ON, Canada, 2Mount Sinai Hospital, Toronto, ON, Canada
11:00 AM	(297) Pulmonary Endarterectomy in CTED: The Pavia Experience M. Pin, A. Sciortino, A. Celentano, L. J. Masiglat, E. Borrelli, V. N. Merli, B. Vanini, C. Klersy, G. Silvaggio, C. Monterosso, A. M. D'Armini. Policlinico San Matteo, Policlinico San Matteo, Pavia, Italy
11:15 AM	(298) Characteristics and Management of Patients Following Pulmonary Embolism: A Focus on Screening for Chronic Thromboembolic Pulmonary Hypertension M. Kanwar1, M. Cole2, M. Gauthier-Loiselle3, A. M. Manceur3, C. Lickert2, M. Greenberg3, P. Lefebvre3, W. Drake2, R. Benza1. 1Allegheny General Hospital, Pittsburgh, PA, 2Actelion Pharmaceuticals Inc., San Fransisco, CA, 3Analysis Group Inc., San Fransisco, CA
11:30 AM	(299) Correlation of Surgical and Computed Tomography Pulmonary Angiographic Level of Disease in Chronic Thromboembolic Pulmonary Hypertension M. C. McInnis1, M. de Perrot2, D. C. Wang1, L. Donahoe2, K. T. Tan1, J. Kavanagh1. 1Department of Medical Imaging, University of Toronto, Toronto, ON, Canada, 2Department of Surgery, University of Toronto, Toronto, ON, Canada
11:45 AM	(300) Medical and Surgical Management of ECLS as Bridge to Recovery and Transplantation for Pulmonary Hypertension: A Large Single Center Experience E. B. Rosenzweig1, W. D. Gannon2, C. L. Agerstrand3, D. Abrams3, D. Brodie3, M. D. Bacchetta2. 1Pediatrics and Medicine, Columbia University Medical Center - NYP, New York, NY, 2Surgery, Vanderbilt University Medical Center, Nashville, TN, 3Medicine, Columbia University Medical Center - NYP, New York, NY

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: EEP
Secondary Audience: HF/HTX, MCS

Chairs: Richard Dorent, MD and Van Khue Ton, MD, PhD
 

10:15 AM	(301) Costs Associated with the First Clinical Trial Evaluating the Safety and Efficacy of the Thoracotomy Approach for Implantation of a Small Intrapericardial Centrifugal LVAD N. A. Mokadam1, E. McGee2, G. Wieselthaler3, D. T. Pham4, S. Bailey5, G. Pretorius6, T. Boeve7, E. Ismyrloglou8, M. Strueber9. 1The Ohio State University Wexner Medical Center, Columbus, OH, 2Loyola University Medical Center, Maywood, IL, 3University of California San Francisco, San Francisco, CA, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Allegheny Health Network, Pittsburgh, PA, 6University of California San Diego, La Jolla, CA, 7Spectrum Health, Grand Rapids, MI, 8Medtronic, Maastricht, Netherlands, 9Newark Beth Israel Medical Center, Newark, NJ
10:30 AM	(302) Cost-Effectiveness of a Small Intrapericardial Centrifugal LVAD versus Medical Management and Heart Transplantation S. Silvestry1, C. Mahr2, M. S. Slaughter3, W. C. Levy2, R. K. Cheng2, D. M. May4, E. Ismyrloglou5, S. I. Tsintzos6, E. Tuttle7, K. Cook7, E. Birk7, W. G. Cotts8. 1Florida Hospital Transplant Institute, Orlando, FL, 2University of Washington, Seattle, WA, 3University of Louisville, Louisville, KY, 4Medtronic, Mounds View, MN, 5Medtronic, Maastricht, Netherlands, 6Medtronic, Tolochenaz, Switzerland, 7Analysis Group, Menlo Park, CA, 8Advocate Christ Medical Center, Oak Lawn, IL
10:45 AM	(303) Cost Effectiveness of Using Hepatitis C Virus (HCV)-Viremic Hearts for Transplantation into HCV-Negative Recipients C. Logan1, I. Yumul2, S. Aslam1, N. Martin1. 1University of California, San Diego, San Diego, CA, 2University of Iowa, Iowa City, IA
11:00 AM	(304) Disparities in Utilization of Hepatitis C Virus Positive Hearts for Transplantation C. Wainaina1, J. Trageser1, A. Hahn1, C. Lay2, V. Pretorius2, S. Aslam2. 1Lifesharing, San Diego, CA, 2University of California, San Diego, San Diego, CA
11:15 AM	(305) Validating Patient Prioritization in the 2018 Revised UNOS Heart Allocation System: A Single Center Experience A. Nayak, Y. Ko, N. Chesnut, A. Pekarek, R. T. Cole, K. Bhatt, D. Gupta, M. Burke, S. R. Laskar, T. S. Attia, A. Smith, J. Vega, A. A. Morris. Emory University, Atlanta, GA
11:30 AM	(306) Consequences of a Revised Heart Allocation System on the Cost Effectiveness of Cardiac Transplantation in the United States: Game Theory Based Insights M. Saltzberg. Comprehensive Heart Failure and Transplant Program, Medical College of Wisconsin, Milwaukee, WI
11:45 AM	(307) Commercial Airlines as a Viable, Safe and Cost Effective Way for Transporting the Donor Hearts across the Country: Single Center Experience K. Bala Krishnan1, K. Suresh Rao2, M. K. Tanguturu2, M. Rajam1, A. Aravind2, J. Dushyanthan2, R. Subramanian2, V. Ramanan2. 1Cardiac Surgery, Fortis Malar Hospital, Chennai, India, 2Cardiac Anesthesia & Critical Care, Fortis Malar Hospital, Chennai, India

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: HF/HTX

Session Summary: This symposium will focus on changing disease epidemiology and outcomes; role of noninvasive surveillance, particularly novel approaches such as PET; advanced coronary imaging for early CAV including intracoronary imaging, plaque characterization and intracoronary haemodynamics; pharmacologic therapy including mTORi and non-immune based strategies such as antiplatelet and lipid lowering therapies, and end with a captivating debate on the role of revascularization and defibrillators for CAV treatment.

Chairs: Kyung-Hee Kim, MD, PhD and Stephan Ensminger, MD, DPhil
 

10:15 AM	Shifting CAV Landscape: Definitions, Epidemiology, and Pathophysiology Michael Pham, MD, California Pacific Medical Center, San Francisco, CA, USA
10:30 AM	Resisting Invasion: Traditional and Novel Non-Invasive Imaging Surveillance for CAV Sharon Chih, MBBS, PhD, University of Ottawa Heart Institute, Ottawa, ON, Canada
10:45 AM	New Tricks for an Old Dog: Intracoronary Imaging and Hemodynamics - A New Classification for CAV? Tor S. Clemmensen, MD, Aarhus University Hospital, Skejby, Denmark
11:00 AM	If I Knew Then What I Know Now: Old and New Drugs for CAV Prevention and Regression Yael Peled, MD, Sheba Medical Center, Tel Hashomer, Israel
11:15 AM	CASE PRESENTATION: Young Man s/p AMR Treatment Who Later Died Suddenly - What Should Have Been Done? Livia Goldraich, MD, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
11:20 AM	DEBATE: Preventing the Invasion of the Body Snatchers: All Patients with CAV Should Have Revascularization and Defibrillators (PRO) Howard Eisen, MD, Pennsylvania College of Medicine, Hershey, PA, USA
11:35 AM	DEBATE: Preventing the Invasion of the Body Snatchers: All Patients with CAV Should Have Revascularization and ICDs (CON) Mandeep Mehra, MD, FRCP, FACC, FESC, Brigham and Women's Hospital, Boston, MA, USA
11:50 AM	10-min Panel Discussion

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: LF/LTX
Secondary Audience: PH

Session Summary: Lung allocation in the United States recently moved to broader geographic sharing. This symposium will review lung allocation throughout the world as it relates to this concept. Topics will include an overview of international lung allocation, the US lung allocation system, review of modeled data on this principle, updated US data available since policy implementation, and a review of this concept as it affects allocation over greater distances in Canada and Australia.

Chairs: Duane M. Davis, MD and James L. Lordan, MB, FRCP
 

10:15 AM	Lung Allocation Systems: Similarities and Differences Jens Gottlieb, MD, Hannover Medical School, Hannover, Germany
10:30 AM	Q&A
10:35 AM	Changes in US Lung Allocation: Support for Broader Sharing Marie Budev, DO, MPH, Cleveland Clinic, Cleveland, OH, USA
10:50 AM	Q&A
10:55 AM	Implementation of 250 Nautical Miles as the First Region of Lung Allocation in the US: Early Results Kevin Chan, MD, University of Michigan, Ann Arbor, MI, USA
11:10 AM	Q&A
11:15 AM	Effects of Distance on Lung Allocation in Australia/New Zealand Dan Chambers, MBBS, FRACP, The Prince Charles Hospital, Brisbane, Australia
11:35 AM	Q&A
11:35 AM	Effects of Distance on Lung Allocation in Canada Alim Hirji, MD, University of Alberta, Edmonton, AB, Canada
11:50 AM	Q&A

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS

Chairs: Emil Najjar, MD and Ulrich Jorde, MD
 

10:15 AM	(308) Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices J. Axelrad1, A. S. Faye2, A. Pinsino3, B. Cagliostro3, A. Thanataveerat4, L. Effner3, F. M. Pineda3, A. R. Garan3, H. Takayama5, K. Takeda5, Y. Naka5, P. C. Colombo3, T. Gonda2, M. Yuzefpolskaya3. 1Gastroenterology, NYU Langone, NYC, NY, 2Gastroenterology, Columbia University Medical Center, NYC, NY, 3Cardiology, Columbia University Medical Center, NYC, NY, 4Biostatistics, Columbia University Medical Center, NYC, NY, 5CT Surgery, Columbia University Medical Center, NYC, NY
10:30 AM	(309) Hemocompatibility Related Outcomes of Centrifugal and Axial Flow LVADs: An IMACS Registry Analysis S. J. Forest, Y. Xia, O. Saeed, S. Patel, U. Jorde, D. J. Goldstein. Montefiore Medical Center, Bronx, NY
10:45 AM	(310) Promising Novel Treatment with Intravenous Bevacizumab for Refractory Gastrointestinal Bleeding from Angiodysplastic Lesions in Patients Supported with a Continuous-Flow Left Ventricular Assist Device: A Pilot Study R. Asleh, S. D. Schettle, S. Maltais, R. C. Daly, V. Iyer, J. M. Stulak, R. Rodeheffer. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
11:00 AM	(311) Prediction of GIB Using R2 CHA2DS2 VASc Risk Score A. Critsinelis1, H. Lamba1, S. Chatterjee1, F. Cheema1, A. Civitello1, R. Delgado1, A. Nair1, A. Shafii2, G. Loor1, T. Rosengart1, O. Frazier1, J. Morgan1. 1Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Texas Heart Institute at Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX
11:15 AM	(312) Experimental Venous Congestion Causes Peripheral Release of Angiopoietin-2 and Tissue Necrosis Factor-α - A New Insight into the Pathophysiology of Gastrointestinal Bleeding in CF-LVAD Patients P. C. Colombo1, F. Castagna1, D. Onat1, S. M. Lagana2, W. Y. Ka1, E. A. Royzman1, A. S. Faye3, J. E. Axelrad4, T. A. Gonda3, A. R. Garan5, H. Takayama6, K. Takeda6, Y. Naka6, G. Parkis7, M. Yuzefpolskaya1, R. Demmer8. 1Cardiology, Columbia University Medical Center, New York, NY, 2Pathology & Cell Biology, Columbia University Medical Center, New York, NY, 3Digestive & Liver Diseases, Columbia University Medical Center, New York, NY, 4Gastroenterology, New York University, New York, NY, 5Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, 6Surgery, Columbia University Medical Center, New York, NY, 7Columbia University Medical Center, New York, NY, 8Epidemiology and Community Health, University of Minnesota, Minneapolis, MN,
11:30 AM	(313) Digoxin Restores Angiogenic Equilibrium in CF- LVAD Patients S. Vukelic1, S. Patel1, P. Vlismas1, T. Chinnadurai1, D. Sims1, S. Murthy1, J. Shin1, O. Saeed1, N. Sibinga2, S. Forest3, D. Goldstein3, U. Jorde1. 1Cardiology, Montefiore MC AECOM, New York, NY, 2Cardiology, AECOM, New York, NY, 3Cardiothoracic & Vascular Surgery, Montefiore MC AECOM, New York, NY
11:45 AM	(314) Gastrointestinal Angiodysplasia is Part of the Vascular Pathophysiology of Advanced Heart Failure S. R. Patel, S. Vukelic, J. Kwah, T. Chinnadurai, O. Saeed, D. Goldstein, U. P. Jorde. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: BSTR
Secondary Audience: LTX, PEDS, PATH

Chairs: Bart M. Canaudenaerde, MSc, PhD and Stephen C. Juvet, MD, PhD, FRCPC
 

12:15 PM	(320) Development of a New Local Therapeutic Approach for BOS: Efficacy of Imatinib Loaded -antiCD44 Coated Gold Nanoparticles In Vitro and In Vivo F. Meloni1, R. Di Paola2, P. Morbini3, L. Pandolfi4, V. Frangipane4, E. Gugliandolo2, E. Cova5, M. Colombo6, D. Prosperi6, P. Vitulo7, G. Ferrario8, R. Fusco2, C. Pacini6, R. Siracusa2, S. Cuzzocrea2. 1Internal Medicine, University of Pavia, Pavia, Italy, 2Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy, 3Molecular Medicine, University of Pavia, Pavia, Italy, 4Respiratory Diseases, IRCCS San Matteo, Pavia, Italy, 5Pathology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 6Department of Biotechnology and Bioscience, University of Milano Bicocca, Milan, Italy, 7Respiratory Disease Unit, IRCCS ISMETT, Palermo, Italy, 8Pathologysection Department of Molecular Medicine, University of Pavia, Pavia, Italy
12:30 PM	(316) B Cells Drive iBALT Formation in a Mouse Model of Chronic Lung Allograft Dysfunction N. F. Smirnova1, T. M. Conlon2, C. Morrone2, A. O. Yildirim2, O. Eickelberg1. 1PSCCM, University of Colorado - Anschutz Medical Campus, Aurora, CO, 2Comprehensive Pneumology Center, Munich, Germany
12:45 PM	(317) Linking CLAD in Lung Transplant Recipients after 3 Years Follow Up with Transplant Arteriosclerosis in Humanized Mice T. Siemeni1, A. Knöfel1, F. Ius1, J. Salman1, W. Sommer1, M. Avsar1, R. Poyanmehr1, C. Kühn1, C. Falk2, I. Tudorache1, A. Haverich1, G. Warnecke1. 1Hannover HTTG, Hannover, Germany, 2Hannover Transplant Immunology, Hannover, Germany
1:00 PM	(318) Pulmonary Antibody-Mediated Rejection (AMR) Accelerates Aging-Evidence from Whole Genome DNA Methylation Sequencing S. Agbor-Enoh1, F. Seifuddin1, M. Pirooznia2, M. Jang1, H. Valantine1. 1Genomic Research Alliance for Transplantation (GRAfT), Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, 2Genomic Research Alliance for Transplantation (GRAfT), Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, MD
1:15 PM	(319) Increased NKG2C+ Natural Killer Cells in Bronchoalveolar Lavage Precede CMV Viremia and Are Associated with CLAD or Death in Lung Transplant Recipients D. R. Calabrese1, T. Chong1, A. S. Wang1, J. P. Singer1, M. Gottschall2, S. R. Hays1, J. A. Golden1, J. Kukreja3, Q. Tang3, J. R. Greenland4. 1Department of Medicine, University of California San Francisco, San Francisco, CA, 2Department of Clinical Lab Medicine, University of California San Francisco, San Francisco, CA, 3Department of Surgery, University of California San Francisco, San Francisco, CA, 4Medical Service, VA Health Care System, San Francisco, CA
1:30 PM	(7) A Novel Injury Site-Targeted Complement Inhibitor Which Protects against Lung Transplant Ischemia Reperfusion Injury C. Li1, K. Patel2, P. Allen2, Z. TU1, J. Kilkenny1, C. Wallace1, S. Nadig1, S. Tomlinson1, C. Atkinson1. 1Departments of Microbiology and Immunology, and Surgery, Medical University of South Carolina, Charleston, SC, 2Department of Surgery, Medical University of South Carolina, Charleston, SC
1:45 PM	(321) Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation C. Heim1, J. Mauer1, A. Kuckhahn1, J. Distler1, B. Spriewald1, M. Ramsperger-Gleixner1, M. Weyand1, S. M. Ensminger2. 1University of Erlangen, Erlangen, Germany, 2University of Luebeck, Lubeck, Germany

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: HF/HTX

Chairs: Jorge Silva Enciso, MD and Maria A. Castel, MD, PhD
 

12:15 PM	(322) PH in Heart Transplant (HT) Candidates: Don’t Look at Ghosts, Search the Evil in the Details M. Masetti, A. Moretta, A. Russo, F. Dardi, M. Palazzini, S. Martin Suarez, A. Loforte, F. Grigioni, N. Galiè, L. Potena. Cardiovascular Department, Bologna University Hospital, Bologna, Italy
12:30 PM	(323) Ratio of Systolic Blood Pressure to Pulmonary Capillary Wedge Pressure Ratio: A Novel Prognostic Marker in Chronic Heart Failure N. Narang, T. Imamura, J. E. Blair, L. Holzhauser, I. Ebong, M. N. Belkin, A. Kanelidis, A. Oehler, D. Yu, T. Fujino, D. Nitta, B. Chung, A. Nguyen, B. A. Smith, J. Raikhelkar, N. Sarswat, G. H. Kim, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago Medical Center, Chicago, IL
12:45 PM	(324) Association between Central Hemodynamics and Glomerular Filtration Rate in Patients with Advanced Heart Failure E. Bobbio1, S. Esmaily2, E. Bollano3, S. Bartfay3, P. Dahlberg3, G. Dellgren4, K. Karason3. 1Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenbug, Sweden, 2Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 3Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden, 4Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden
1:00 PM	(325) Use of Remote Dielectric Sensing (ReDS) as Point-of-Care Testing Following Heart Failure Hospitalization and Risk of 30-Day Readmission M. H. Barghash1, A. Lala1, G. Giustino1, A. Parikh1, J. Ullman1, S. S. Mitter1, S. Konje2, B. Keith1, N. Moss1, D. Mancini1, M. G. Trivieri1, J. Contreras1, D. Burkhoff3, S. P. Pinney1. 1The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, NY, 2Department of Medicine, Mount Sinai Hospital, New York, NY, 3Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY
1:15 PM	(326) Lung Ultrasound May Reduce Heart Failure Hospitalizations: Preliminary Results from the LUS-HF Trial M. Rivas-Lasarte1, A. Maestro-Benedicto1, J. Fernandez-Martinez1, J. Álvarez-García1, E. Solé-González1, L. López-López2, S. Mirabet-Perez2, V. Brossa-Loidi2, A. Sionis1, J. Cinca1, E. Roig2. 1Cardology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1:30 PM	(327) Cardiac Autonomic Nerves Stimulation Improves Hemodynamics: A Pilot Study in Advanced Heart Failure Patients T. Diaz1, C. Marin y Kall2, J. Boehmer3, M. Cowie4, A. Mebazaa5, M. Cuchiara6. 1Pacífica Salud Hospital Punta Pacífica, Panama City, Panama, 2International Medicine Institute, University of Miami, Miami, FL, 3Penn State Hershey Heart and Vascular Institute, Hershey, PA, 4National Heart and Lung Institute, Imperial College London, London, United Kingdom, 5University Paris Diderot, Paris, France, 6NeuroTronik Inc, Durham, NC
1:45 PM	(328) Cell Therapy is Associated with Reduction of Functional Mitral Regurgitation in Cardiomyopathy Patients with High End-Diastolic Volumes S. Frljak1, G. Zemljic1, G. Poglajen1, A. Cerar1, M. Jaklic1, F. Haddad2, B. Vrtovec1. 1Advanced Heart Failure and Transplantation Center, UMC Ljubljana, Ljubljana, Slovenia, 2Stanford Cardiovascular Institute, Stanford, CA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: HF/HTX
Secondary Audience: PATH

Chairs: Eugene C. DePasquale, MD and Marta Farrero Torres, MD, PhD
 

12:15 PM	(329) End Stage Renal Disease after Cardiac Transplantation: An 11-Year National Cohort Study M. Kosztowski, J. M. Garonzik-Wang, A. Massie, R. S. Higgins, D. L. Segev, A. Kilic. Department of Surgery, Johns Hopkins, Baltimore, MD
12:30 PM	(330) HLA-G 14BP Polymorphism Matching Protects against Development of Post-Transplant Malignancy Following Heart Transplantation M. B. Adamson1, R. V. Ribeiro1, F. Yu1, J. Lazarte1, K. Runeckles2, C. Manlhiot2, V. Rao1, D. Delgado1. 1Peter Munk Cardiac Centre, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada
12:45 PM	(331) The Impact of New Onset Post-Transplant Diabetes on Outcomes after Heart Transplantation A. R. Vest1, W. S. Cherikh2, S. M. Noreen2, J. Stehlik3, K. K. Khush4. 1Tufts Medical Center, Boston, MA, 2United Network for Organ Sharing (UNOS), Richmond, VA, 3University of Utah, Salt Lake City, UT, 4Stanford University, Stanford, CA
1:00 PM	(332) Severe Acute Kidney Injury after Cardiac Transplantation is a Marker of Poor Early Outcome and Impacts on Late Renal Function - A UK Cohort Study L. Wang1, T. Wang2, S. N. Rushton3, A. J. Fisher1, N. S. Sheerin4, J. H. Dark1. 1Cardiothoracic Services, Freeman Hospital, Newcastle upon Tyne, United Kingdom, 2Univeristy College London, London, United Kingdom, 3Statistics and Clinical Studies, National Health Service Blood and Transplant, Bristol, United Kingdom, 4Renal Services, Freeman Hospital, Newcastle upon Tyne, United Kingdom
1:15 PM	(333) The Impact of Complement-Binding Donor-Specific Antibodies on Adverse Events Long-Term after Heart Transplantation J. A. Kobashigawa, M. Kittleson, D. H. Chang, E. Kransdorf, R. Levine, S. Dimbil, C. Kawata, M. Olymbios, A. Velleca, L. Czer, X. Zhang, J. Chung, J. Patel. Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
1:30 PM	(439) Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors Y. D. Barac, O. Jawitz, J. Klapper, J. Schroder, M. Daneshmand, C. Patel, C. Milano, M. Hartwig. Duke University Medical Center, Durham, NC
1:45 PM	(335) Association between AT1R Autoantibody with Adverse Outcomes in Patients Bridged to Heart Transplant Using Continuous Flow Ventricular Assist Device V. Q. Chau1, K. Nicholson1, M. Flattery1, F. McDougan2, K. Desai1, P. Uber1, G. Gupta3, P. Kimball2, K. B. Shah1. 1Division of Cardiology and Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, 2Division of Transplant Surgery, Virginia Commonwealth University, Richmond, VA, 3Division of Transplant Nephrology, Virginia Commonwealth University, Richmond, VA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: LF/LTX
Secondary Audience: BSTR, PATH

Chairs: Alejandro M. F. Bertolotti, Sr., MD and Clemens Aigner, MD
 

12:15 PM	(336) The New View of Pre-Lung Transplant Determinants for Predicting De Novo Donor Specific Antibody and Transplant Rejection A. Zhang1, D. Thomas1, J. Allen1, K. McCurry2, M. Budev2. 1Allogen Laboratories, Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH
12:30 PM	(337) Inflammatory Events Precede Development of De Novo DSA after Lung Transplantation I. L. Ponor1, A. Jackson2, A. Cochrane3, I. Tunc4, M. Jang4, J. Mathew5, N. D’Emilio6, H. I. Luikart6, I. Timofte7, A. Brown8, P. Shah9, S. Nathan8, A. Iacono7, J. B. Orens9, C. Marboe10, G. J. Berry11, K. Khush12, H. Valantine13, S. Agbor-Enoh14. 1Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, 2Medicine-Immunogenetics and Transplantation Immunology, The Johns Hopkins University, Baltimore, MD, 3Medicine, Inova Fairfax Hospital, Fairfax, VA, 4Division of Intramural Research, National Heart, Lung, and Blood Institute -NIH, Bethesda, MD, 5Pulmonary and Critical Care, The Johns Hopkins School of Medicine, Baltimore, MD, 6Division of Cardiology, Stanford University School of Medicine, Stanford, CA, 7Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD, 8Inova Heart and Vascular Institute, Inova Fairfax Hospital, Fairfax, VA, 9Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, 10Pathology, New York Presbyterian University Hospital of Cornell and Columbia, New York, NY, 11Pathology, Stanford University School of Medicine, Palo Alto, CA, 12Cardiology, Stanford University School of Medicine, Palo Alto, CA, 13Division of Intramural Research, National Heart, Lung, and Blood Institute- NIH, Bethesda, MD, 14Division of Intramural Research, National Heart, Lung, and Blood Institute-NIH, Bethesda, MD
12:45 PM	(338) Transcriptome Profiles of the Circulating Extracellular Vesicles in Acute Lung Allograft Rejection S. Joo1, M. Puhka2, R. Krebs1, P. Mattila3, M. Kankainen3, K. Dhaygude1, E. Rouvinen1, K. Lemström1. 1Transplantation Laboratory, University of Helsinki, Helsinki, Finland, 2EV core, Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland, 3Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
1:00 PM	(339) Profiling Pre-Existing Autoantibodies for Prediction of Primary Graft Dysfunction V. Kaza1, C. Zhu1, L. Feng1, A. Reddy2, L. Terada1, M. Mohanka1, C. Lacelle3, S. Bollineni1, A. Banga1, J. Mullins1, F. Torres1, Q. Li1. 1Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 2Internal Medicine, Southwest Pulmonary Associates, Dallas, TX, 3UT Southwestern Medical Center, Dallas, TX
1:15 PM	(340) Correlation between Early B and NK Cell Frequencies and in Relation to CLAD Development and PGD 24h after Lung Transplantation A. Knoefel1, F. Ius1, T. Nakagiri1, J. Salman1, T. Siemeni1, W. Sommer1, C. Kuehn1, M. Avsar1, T. Welte2, I. Tudorache1, C. S. Falk3, A. Haverich1, G. Warnecke1. 1HTTG, MHH, Hannover, Germany, 2Pneumology, MHH, Hannover, Germany, 3Transplant Immunology, MHH, Hannover, Germany
1:30 PM	(341) miRNAs in Lung Transplantation: Small Things That Make Big Differences V. Vaira1, V. S. Musso2, A. Terrasi1, G. Gaudioso3, S. Ferreo3, V. Rossetti3, L. C. Morlacchi3, D. Tosi2, A. Palleschi2. 1Università degli Studi of Milan, Milan, Italy, 2Thoracic Surgery and Lung Transplant Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy, 3Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
1:45 PM	(342) Risk Factors for Primary Graft Dysfunction in Patients with Cystic Fibrosis Receiving Lung Transplants J. A. Martin1, M. K. Porteous1, E. Cantu2, D. J. Lederer3, L. Snyder4, A. Weinacker5, J. B. Orens6, P. D. Shah6, V. N. Lama7, J. McDyer8, K. M. Wille9, C. A. Hage10, J. Singer11, L. B. Ware12, M. Oyster1, M. Brown1, J. D. Christie1, J. M. Diamond1. 1Medicine, University of Pennsylvania, Philadelphia, PA, 2Surgery, University of Pennsylvania, Philadelphia, PA, 3Medicine, Columbia University, New York, NY, 4Medicine, Duke University, Durham, NC, 5Medicine, Stanford University, Palo Alto, CA, 6Medicine, Johns Hopkins University, Baltimore, MD, 7Medicine, University of Michigan, Ann Arbor, MI, 8Medicine, University of Pittsburgh, Pittsburgh, PA, 9Medicine, University of Alabama at Birmingham, Birmingham, AL, 10Medicine, Indiana University, Indianapolis, IN, 11Medicine, University of California San Francisco, San Francisco, CA, 12Medicine, Vanderbilt University, Nashville, TN

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: LF/LTX
Secondary Audience: EEP, PATH

Chairs: Sara J. Shumway, MD and Ahmed Menaouar, PhD
 

12:15 PM	(343) High Calculated Panel Reactive Antigen (cPRA) is Associated with Decreased Rates of Transplantation and Increased Waitlist Mortality in Lung Transplantation: A UNOS/OPTN Registry Analysis Y. D. Barac, M. Mulvihill, O. Jawitz, J. Haney, J. Klapper, M. Daneshmand, M. Hartwig. Duke University Medical Center, Durham, NC
12:30 PM	(344) Effect of Lung Protective Ventilation in Organ Donors on Lung Procurement and Recipient Survival: Results from a Nationwide Cohort Study H. Mal1, G. Santin2, C. Legeai2, C. Cantrelle2, L. Durand2, G. Cheisson3, L. Saint-Marcel4, I. Pipien2, L. Durin2, O. Bastien2, R. Dorent2. 1Hôpital Bichat - APHP, Paris, France, 2Direction Prélèvement Greffe Organes Tissus, Agence de la Biomédecine, Saint-Denis, France, 3Hôpital Kremlin-Bicêtre, AP-HP, Kremlin Bicêtre, France, 4Hôpital Genevois, Annecy, France
12:45 PM	(345) Despite Growing Utilization, the Use of Public Health Service Increased Risk Donors for Lung Transplantation is Not Associated with Increased Mortality D. J. Hall1, E. I. Jeng1, J. A. Gregg2, A. Pelaez3, A. Emtiazjoo3, S. Chandrashekaran3, M. Pipkin1, T. Beaver1, T. N. Machuca1. 1Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, FL, 2Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, FL, 3Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL
1:00 PM	(346) Donor-Bound Predictors for Primary Graft Function in Lung Transplantation - Results from a Prospective Multicenter Study A. Benazzo1, S. Schwarz1, M. Muckenhuber1, T. Schweiger1, R. Vamos Ferenc2, S. Taghavi1, G. Lang3, S. Azad4, P. Jaksch1, M. Cypel5, W. Klepetko1, S. Keshavjee6, K. Hoetzenecker1. 1Thoracic Surgery, Medical University of Vienna, Vienna, Austria, 2Thoracic Surgery, Medical University of Budapest, Budapest, Hungary, 3Division of Thoracic Surgery, University of Vienna, Vienna, Austria, 4Toronto Lung Transplant Program Toronto General Hospital, University Health Network University of Toronto, Toronto, ON, Canada, 5Toronto Lung Transplant Program Toronto General Hospital, University Health Network, University of Toronto, Ontario, ON, Canada, 6Toronto Lung Transplant Program Toronto General Hospital, Toronto General Hospital University Health Network University of Toronto, Toronto, ON, Canada
1:15 PM	(347) Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry A. Y. Choi1, O. K. Jawitz2, V. Raman2, Y. Barac2, M. S. Mulvihill2, C. Moore2, M. G. Hartwig2. 1Duke University School of Medicine, Durham, NC, 2Department of Surgery, Duke University Medical Center, Durham, NC
1:30 PM	(348) The Impact of Removing the Donor Service Area (DSA) as the First Unit of Allocation for Lungs in the United State R. R. Lehman1, K. Uccellini1, E. Lease2, R. Daly3, K. M. Chan4. 1United Network for Organ Sharing, Richmond, VA, 2University of Washington, Seattle, WA, 3Mayo Clinic, Rochester, MN, 4University of Michigan, Ann Arbor, MI
1:45 PM	(349) Donor-Recipient Weight Mismatch and Primary Graft Dysfunction Risk Post-Lung Transplantation A. Hirji, D. Li, A. Kapasi, J. Weinkauf, D. Lien, K. Halloran. Lung Transplant Program, University of Alberta, Edmonton, AB, Canada

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: MCS
Secondary Audience: NHSAH

Chairs: Ivan Knezevic, MD and Jose Gonzalez-Costello, MD
 

12:15 PM	(350) Routine Right Heart Catheterization in LVAD Patients Awaiting Heart Transplant: What is the Appropriate Surveillance Interval? D. Ruan1, M. Farr2, V. Topkara2, A. R. Garan2, J. Sanchez1, P. Kurlansky3, M. Yuzefpolskaya2, P. Colombo2, H. Takayama4, Y. Naka4, K. Takeda4. 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 3Department of Surgery, Columbia University Irving Medical Center, New York, NY, 4Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY
12:30 PM	(351) Cardiac and Cerebrovascular Response to Exercise in the Setting of Mechanical Circulatory Support among Individuals with Advanced Heart Failure T. Tran1, G. Coe1, M. Bradley1, K. O'Gean1, M. Spotts1, M. Ostertag1, S. Laing1, L. C. Prado1, C. Cornwell2, J. Paul1, W. Cornwell1. 1University of Colorado, Aurora, CO, 2Ohio State University, Columbus, OH
12:45 PM	(352) Echocardiographic Predictors of Left Ventricle Unloading after LVAD Implantation A. Duran, A. Guha, A. Bhimaraj, J. Estep, B. Trachtenberg, M. H. Park, N. Salam, F. Hussain, I. Hussain. Houston Methodist Hospital, Houston, TX
1:00 PM	(353) Comparison of Exercise Hemodynamics in Patients Supported with Centrifugal and Axial Flow Left Ventricular Assist Devices N. Moss1, A. Parikh1, V. Rakita2, A. Lala1, S. Mitter1, J. Roldan1, A. Cuca1, M. Barghash1, J. Contreras1, S. Pinney1, A. Anyanwu1, D. M. Mancini1. 1Mount Sinai Hospital, New York, NY, 2Temple University Hospital, Philadelphia, PA
1:15 PM	(354) High Right Ventricular Afterload is Associated with Impaired Exercise Tolerance in LVAD Patients V. Ton1, L. Dees1, E. Sorensen1, E. Feller1, R. Madathil1, D. Kaczorowski1, B. Griffith1, R. J. Tedford2, G. Ramani1. 1University of Maryland School of Medicine, Baltimore, MD, 2Medical University of South Carolina, Charleston, SC
1:30 PM	(355) Exercise-Induced Hypoxemia Predicts Heart Failure Hospitalization and Death in Patients Supported with Left Ventricular Assist Devices D. M. Koerber1, A. N. Rosenbaum2, T. P. Olson2, S. Kushwaha2, J. Stulak3, S. Maltais3, A. Behfar1. 1Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, 2Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN
1:45 PM	(356) Prospective Evaluation of LVAD Risk Scores’ Capacity to Predict Cardiopulmonary Exercise Parameters A. Dorken1, P. Öztürk2, E. Demir3, Ç. Engin2, S. Nalbantgil3, T. Yağdi2, M. Özbaran2. 1Ege University Faculty of Medicine, Izmir, Turkey, 2Cardiovascular Surgery, Ege University Faculty of Medicine, Izmir, Turkey, 3Cardiology, Ege University Faculty of Medicine, Izmir, Turkey